• About Amgen
  • Science
  • Corporate Giving
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • Reimbursement Connection®

  • Overview
  • Amgen™ Oncology Assistance
  • Aranesp®
    (darbepoetin alfa)
  • Neulasta®
    (pegfilgrastim)
  • NEUPOGEN®
    (Filgrastim)
  • EPOGEN®
    (Epoetin alfa)
  • Sensipar®
    (cinacalcet)
  • Enbrel®
    (etanercept)
  • Kepivance®
    (palifermin)
  • Kineret®
    (anakinra)
  • Vectibix®
    (panitumumab)
Reimbursement Connection®
NCD Updates
The problems are complex...
The solution is simple...

... Amgen's Reimbursement Connection®

provides help to take the confusion out of reimbursement, coverage, and patient assistance.

Hotline: 1-800-272-9376

New Amgen Oncology Assistance

Online Guides to:

Insurance Verification
Patient Assistance
Billing and Claims Support

Detail by Amgen Product:

Aranesp® (darbepoetin alfa)
Neulasta® (pegfilgrastim)
NEUPOGEN® (Filgrastim)
EPOGEN® (Epoetin alfa)
Sensipar® (cinacalcet HCl)
Enbrel® (etanercept)
Kepivance® (palifermin)
Kineret® (anakinra)
Vectibix® (panitumumab)

 


footer